Physician profile
John C Manuel
NPI 1912153875
$6,133.69
in general payments reported to CMS, 2019-2025
18 companies · $1,318 in 2025
The $1,318 reported for 2025 was more than what 99% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $260 · 2022: $922 · 2023: $1,553 · 2024: $2,081 · 2025: $1,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,938 · Education: $14.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,937.59 |
| Education | $14.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $1,589.70 | 2021-2025 | Entyvio, Eohilia, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,528.41 | 2021-2025 | Xifaxan, Trulance, Plenvu |
| Abbvie INC. | $798.02 | 2022-2025 | |
| Qol Medical, LLC | $676.45 | 2021-2025 | Sucraid, Sucraid |
| Janssen Biotech, INC. | $452.91 | 2022-2025 | Simponi Aria, Simponi, Stelara |
| Lucid Diagnostics INC. | $399.08 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $200.45 | 2022-2024 | Dificid |
| Organon LLC | $113.72 | 2023-2025 | Renflexis, Hadlima |
| Lilly USA, LLC | $97.76 | 2024 | Omvoh |
| Redhill Biopharma INC. | $68.88 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $42.70 | 2022 | |
| Braintree Laboratories, INC. | $41.36 | 2022-2025 | Suflave, Sutab |
| Regeneron Healthcare Solutions, INC. | $41.22 | 2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $20.96 | 2024 | Voquezna |
| Evoke Pharma, INC. | $17.74 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.86 | 2024 | Gi Genius |
| Aimmune Therapeutics, INC. | $14.25 | 2025 | Vowst |
| Celltrion USA INC. | $14.22 | 2024 | Zymfentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Manuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.